Phase 1, First in Human, Open-Label, Dose-Escalation Study of 609A
Clinical trial NCT03950297 · UNKNOWN
Trial details
- NCT number
- NCT03950297
- Sponsor
- Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-01
- Primary completion
- 2020-10-24
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.